01 3ALNYLAM PHARMS INC
02 1NOVARTIS
01 48106022
01 4Y
01 4Y
01 42029-12-12
Patent Expiration Date : 2029-12-12
US Patent Number : 8106022
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 214103
Patent Use Code : U-2995
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-12-12
Patent Expiration Date : 2029-12-12
US Patent Number : 8106022
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 215515
Patent Use Code : U-3396
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-12-12
Patent Expiration Date : 2029-12-12
US Patent Number : 8106022
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 212194
Patent Use Code : U-2672
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-12-12
Patent Expiration Date : 2029-12-12
US Patent Number : 8106022
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 214012
Patent Use Code : U-4249
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-12-12
